8.68
price up icon6.24%   0.51
after-market Dopo l'orario di chiusura: 8.68
loading

Karyopharm Therapeutics Inc Borsa (KPTI) Ultime notizie

pulisher
03:32 AM

Why Karyopharm Therapeutics Inc. (25K0) stock could rally stronglyQuarterly Growth Report & Verified Momentum Watchlists - ulpravda.ru

03:32 AM
pulisher
Jan 08, 2026

How Karyopharm Therapeutics Inc. stock performs in weak economy2025 Trade Ideas & AI Forecasted Entry and Exit Points - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will Karyopharm Therapeutics Inc. (25K0) stock rise with strong economyMarket Growth Summary & Scalable Portfolio Growth Ideas - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Why Karyopharm Therapeutics Inc. stock attracts global investorsRate Hike & High Accuracy Investment Entry Signals - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Is Karyopharm Therapeutics Inc. stock attractive for income investorsPortfolio Gains Report & Fast Momentum Entry Tips - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will Karyopharm Therapeutics Inc. stock remain a Wall Street favoriteTrend Reversal & Daily Chart Pattern Signals - ulpravda.ru

Jan 08, 2026
pulisher
Jan 02, 2026

Karyopharm Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener

Jan 02, 2026
pulisher
Jan 02, 2026

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView — Track All Markets

Jan 02, 2026
pulisher
Jan 02, 2026

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire

Jan 02, 2026
pulisher
Dec 30, 2025

MACD Signal: Why Karyopharm Therapeutics Inc stock attracts global investors2025 Winners & Losers & Safe Capital Growth Tips - moha.gov.vn

Dec 30, 2025
pulisher
Dec 24, 2025

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Dec 24, 2025
pulisher
Dec 22, 2025

KPTI (Karyopharm Therapeutics Inc) has impressive results - uspostnews.com

Dec 22, 2025
pulisher
Dec 22, 2025

Karyopharm Therapeutics (FRA:25K0) EV-to-OCF : -2.79 (As of Dec. 22, 2025) - GuruFocus

Dec 22, 2025
pulisher
Dec 21, 2025

Why Karyopharm Therapeutics Inc. (25K0) stock could be next leader2025 Earnings Impact & Growth Focused Investment Plans - Улправда

Dec 21, 2025
pulisher
Dec 20, 2025

Can Karyopharm Therapeutics Inc. stock resist sector downturnsJuly 2025 Market Mood & High Accuracy Trade Alerts - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Is Karyopharm Therapeutics Inc. stock a bargain at current levelsIndustrial Stocks Review & Free Extraordinary Earning Power - bollywoodhelpline.com

Dec 20, 2025
pulisher
Dec 19, 2025

How Karyopharm Therapeutics Inc. stock responds to policy changesWeekly Trend Summary & Fast Entry Momentum Alerts - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Can Karyopharm Therapeutics Inc. stock withstand economic slowdownJuly 2025 Gainers & Precise Swing Trade Entry Alerts - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Will Karyopharm Therapeutics Inc. (25K0) stock beat international competitionQuarterly Portfolio Review & Accurate Entry/Exit Alerts - Улправда

Dec 19, 2025
pulisher
Dec 17, 2025

Piper Sandler names Karyopharm stock as 2026 top pick, maintains $12 target - Investing.com Canada

Dec 17, 2025
pulisher
Dec 12, 2025

Karyopharm Therapeutics’ Earnings Call: Progress Amid Challenges - MSN

Dec 12, 2025
pulisher
Dec 09, 2025

Karyopharm Therapeutics (NASDAQ:KPTI) Stock Price Passes Above 50-Day Moving AverageHere's What Happened - MarketBeat

Dec 09, 2025
pulisher
Dec 08, 2025

Karyopharm to Participate in Baird's Biotech Discovery Series - Karyopharm

Dec 08, 2025
pulisher
Dec 08, 2025

Karyopharm (Nasdaq: KPTI) to discuss myelofibrosis in Baird Biotech Discovery Series chat - Stock Titan

Dec 08, 2025
pulisher
Dec 07, 2025

Published on: 2025-12-10 09:05:07 - earlytimes.in

Dec 07, 2025
pulisher
Dec 06, 2025

Karyopharm Therapeutics (KPTI) Price Target Decreased by 11.70% to 14.11 - MSN

Dec 06, 2025
pulisher
Dec 05, 2025

Is Karyopharm Therapeutics Inc. (25K0) stock among top earnings plays2025 Technical Overview & Safe Capital Growth Tips - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

How Karyopharm Therapeutics Inc. (25K0) stock reacts to new regulationsTrade Volume Summary & Daily Stock Trend Watchlist - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

What makes Karyopharm Therapeutics Inc. (25K0) stock appealing to growth investorsJuly 2025 Volume & Fast Exit and Entry Strategy Plans - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Will Karyopharm Therapeutics Inc. (25K0) stock outperform global peersJuly 2025 PostEarnings & Real-Time Buy Zone Alerts - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Will Karyopharm Therapeutics Inc. (25K0) stock split increase liquidity2025 Big Picture & Fast Gaining Stock Reports - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Will Karyopharm Therapeutics Inc. (25K0) stock announce special dividendMarket Growth Summary & Expert Curated Trade Ideas - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Why global investors buy Karyopharm Therapeutics Inc. (25K0) stockJuly 2025 Highlights & AI Based Buy/Sell Signal Reports - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Karyopharm Therapeutics (KPTI) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 02, 2025
pulisher
Dec 01, 2025

Karyopharm (Nasdaq: KPTI) plans fireside chat at Piper Sandler 37th Healthcare Conference - Stock Titan

Dec 01, 2025
pulisher
Dec 01, 2025

Karyopharm to Participate at the Piper Sandler 37th Annual Healthcare Conference - Karyopharm

Dec 01, 2025
pulisher
Nov 30, 2025

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Nov 30, 2025
pulisher
Nov 28, 2025

Looking at the Narrative for Karyopharm as Financing and Trial Milestones Shift the Outlook - Yahoo Finance

Nov 28, 2025
pulisher
Nov 27, 2025

Karyopharm Therapeutics (NASDAQ:KPTI) Stock Price Passes Below 200 Day Moving AverageWhat's Next? - MarketBeat

Nov 27, 2025
pulisher
Nov 24, 2025

[424B3] Karyopharm Therapeutics Inc. Prospectus Filed Pursuant to Rule 424(b)(3) - Stock Titan

Nov 24, 2025
pulisher
Nov 21, 2025

Is Karyopharm Therapeutics Inc. stock vulnerable to regulatory risks2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Why Karyopharm Therapeutics Inc. (25K0) stock trades below fair valueJuly 2025 Opening Moves & Detailed Earnings Play Strategies - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How Karyopharm Therapeutics Inc. stock reacts to job market dataStock Surge & AI Driven Price Predictions - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is Karyopharm Therapeutics Inc. (25K0) stock undervalued by metrics2025 Investor Takeaways & Daily Stock Trend Watchlist - newser.com

Nov 21, 2025
$106.87
price up icon 0.90%
$34.26
price up icon 1.87%
$118.64
price up icon 10.48%
$99.85
price up icon 1.01%
biotechnology ONC
$337.89
price up icon 5.47%
$175.97
price up icon 3.35%
Capitalizzazione:     |  Volume (24 ore):